Ken Widder

Ken Widder has made 22 investments in companies such as: Calistoga Pharmaceuticals, Pathway Medical Technologies, Femta Pharmaceuticals, Neuraltus Pharmaceuticals, Inova Labs, Naurex, Aptinyx, Pulmonx, CardioMind, Meritage Pharma, Ovalis, XTENT, Proteolix, Aria Biosystems, Leptos Biomedical, Talima Therapeutics, Transcend Medical, TetraLogic Pharmaceuticals, Bayhill Therapeutics, ProteinSimple, Viracta Therapeutics, OncoMed Pharmaceuticals.

Location of Ken Widder is San Ramon, United States.

The free version of Angel Match provides limited data for Ken Widder. Advanced features and premium data such as emails, phone numbers and social media profiles are available only on paid subscription plans.


Ken Widder is a Venture Consultant and he his investment types are: Venture Capital.
Ken Widder focuses investing in industries such as: Biopharma, Biotechnology, Medical, Pharmaceutical, Therapeutics, Health Care, Medical Device.

A short brief about investor:

About

Past investments

  • Calistoga Pharmaceuticals
  • Pathway Medical Technologies
  • Femta Pharmaceuticals
  • Neuraltus Pharmaceuticals
  • Inova Labs
  • Naurex
  • Aptinyx
  • Pulmonx
  • CardioMind
  • Meritage Pharma
  • Ovalis
  • XTENT
  • Proteolix
  • Aria Biosystems
  • Leptos Biomedical
  • Talima Therapeutics
  • Transcend Medical
  • TetraLogic Pharmaceuticals
  • Bayhill Therapeutics
  • ProteinSimple
  • Viracta Therapeutics
  • OncoMed Pharmaceuticals

Social media:

Available after registration.